Smith Asset Management Group »

Mirati Therapeutics shares owned by Smith Asset Management Group

Quarter-by-quarter ownership of Mirati Therapeutics shares owned by Smith Asset Management Group from 13F filings

Historical chart of Smith Asset Management Group investment in Mirati Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mirati Therapeutics held by Smith Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirati Therapeutics by Smith Asset Management Group

Quarter filed Position value Share count Share price at filing
2021-06-30 $8.0k 50 160.00
2021-03-31 $9.0k 50 180.00
2020-12-31 $294k 1.3k 219.40
2020-09-30 $223k 1.3k 166.42
2020-06-30 $106k 930 113.98
2020-03-31 $73k 950 76.84
2019-12-31 $122k 950 128.42
2019-09-30 $74k 950 77.89

More positions owned by Smith Asset Management Group

Apple Common Stock - Long (AAPL)
Microsoft Corp Common Stock - Long (MSFT)
Amazon.com Common Stock - Long (AMZN)
Facebook Common Stock - Long (META)
Alphabet Common Stock - Long (GOOGL)
Nvidia Corp Common Stock - Long (NVDA)
Fortinet Common Stock - Long (FTNT)
Adobe Common Stock - Long (ADBE)
United Parcel Service Common Stock - Long (UPS)
Jpmorgan Chase & Co Common Stock - Long (JPM)
Parker-Hannifin Corp Common Stock - Long (PH)
Target Corp Common Stock - Long (TGT)
Capital One Financial Corp Common Stock - Long (COF)
Paypal Holdings Common Stock - Long (PYPL)
Epam Systems Common Stock - Long (EPAM)

View all positions for Smith Asset Management Group

Top funds holding Mirati Therapeutics

EcoR1 Capital
venBio Select Advisor
Baker Bros. Advisors
Boxer Capital
Sawtooth Asset Management
Braslyn
Tang Capital Management
Paradigm Biocapital Advisors
Pentwater Capital Management
CSS
Hsbc Holdings
Norges Bank Investment Management
Alliancebernstein
Bank Of Montreal
Artal Group

View all funds holding Mirati Therapeutics